Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

български (BG) (279.69 KB - PDF)

View

español (ES) (239.85 KB - PDF)

View

čeština (CS) (283.94 KB - PDF)

View

dansk (DA) (239 KB - PDF)

View

Deutsch (DE) (241.8 KB - PDF)

View

eesti keel (ET) (237.14 KB - PDF)

View

ελληνικά (EL) (282.67 KB - PDF)

View

français (FR) (245.68 KB - PDF)

View

italiano (IT) (238.08 KB - PDF)

View

latviešu valoda (LV) (283.06 KB - PDF)

View

lietuvių kalba (LT) (251.47 KB - PDF)

View

magyar (HU) (253.42 KB - PDF)

View

Malti (MT) (265.77 KB - PDF)

View

Nederlands (NL) (217.72 KB - PDF)

View

polski (PL) (282.55 KB - PDF)

View

português (PT) (218.29 KB - PDF)

View

română (RO) (242.81 KB - PDF)

View

slovenčina (SK) (260.4 KB - PDF)

View

slovenščina (SL) (252.65 KB - PDF)

View

Suomi (FI) (237.94 KB - PDF)

View

svenska (SV) (239.22 KB - PDF)

View

Product information

български (BG) (1.12 MB - PDF)

View

español (ES) (413.23 KB - PDF)

View

čeština (CS) (559.01 KB - PDF)

View

dansk (DA) (619.26 KB - PDF)

View

Deutsch (DE) (409.78 KB - PDF)

View

eesti keel (ET) (394.94 KB - PDF)

View

ελληνικά (EL) (1.78 MB - PDF)

View

français (FR) (455.26 KB - PDF)

View

íslenska (IS) (418.64 KB - PDF)

View

italiano (IT) (432.39 KB - PDF)

View

latviešu valoda (LV) (543.86 KB - PDF)

View

lietuvių kalba (LT) (475.04 KB - PDF)

View

magyar (HU) (577.53 KB - PDF)

View

Malti (MT) (631.26 KB - PDF)

View

Nederlands (NL) (419.67 KB - PDF)

View

norsk (NO) (405.73 KB - PDF)

View

polski (PL) (601.64 KB - PDF)

View

português (PT) (402.62 KB - PDF)

View

română (RO) (490.98 KB - PDF)

View

slovenčina (SK) (616.03 KB - PDF)

View

slovenščina (SL) (568.91 KB - PDF)

View

Suomi (FI) (408.3 KB - PDF)

View

svenska (SV) (413.86 KB - PDF)

View

Latest procedure affecting product information: IAIN/0007/G

15/01/2015

български (BG) (202.54 KB - PDF)

View

español (ES) (148.22 KB - PDF)

View

čeština (CS) (192.56 KB - PDF)

View

dansk (DA) (151.57 KB - PDF)

View

Deutsch (DE) (152.17 KB - PDF)

View

eesti keel (ET) (147.88 KB - PDF)

View

ελληνικά (EL) (200.73 KB - PDF)

View

français (FR) (474.14 KB - PDF)

View

íslenska (IS) (151.76 KB - PDF)

View

italiano (IT) (148.51 KB - PDF)

View

latviešu valoda (LV) (202.11 KB - PDF)

View

lietuvių kalba (LT) (191.42 KB - PDF)

View

magyar (HU) (188.69 KB - PDF)

View

Malti (MT) (194.75 KB - PDF)

View

Nederlands (NL) (151.46 KB - PDF)

View

norsk (NO) (148.31 KB - PDF)

View

polski (PL) (176.01 KB - PDF)

View

português (PT) (151.81 KB - PDF)

View

română (RO) (188.05 KB - PDF)

View

slovenčina (SK) (195.92 KB - PDF)

View

slovenščina (SL) (189.87 KB - PDF)

View

Suomi (FI) (147.96 KB - PDF)

View

svenska (SV) (151.54 KB - PDF)

View

Product details

Name of medicine
Slentrol
Active substance
dirlotapide
International non-proprietary name (INN) or common name
dirlotapide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QA08AB91

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Authorisation details

EMA product number
EMEA/V/C/000116
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
13/04/2007
Revision
7

Assessment history

This page was last updated on

Share this page